Aflibercept (VEGF Trap), a selective humanized IgG1 monoclonal antibody that can block the interaction of VEGF with VEGFR1 and VEGFR2, has been used in combination with pembrolizumab in melanoma [128]. This evidence concerns the gene KDR and melanoma.